Dr. Quinn Dinh

Quinn Dinh, M.D. has more than 12 years of biotechnology medical affairs and R&D experience, with a focus on rare and complex diseases. Dr. Dinh is currently Vice President, Head Medical Affairs at Corbus Pharmaceuticals. Prior to Corbus, he was Therapeutic Area Head Medical Affairs at Alnylam and Head U.S. Genetic Diseases Medical at Shire. Dr. Dinh holds a Medical Doctorate and a Bachelor of Science in Biochemistry from Brown University. He did his postgraduate training at the Harvard Medical School affiliate Brigham and Women’s and Albert Einstein College of Medicine affiliate Beth Israel. He also completed course work at Wharton Executive business leadership program. He was a former co-chair of the annual Academy of Pharmaceutical Physicians and Investigators (APPI), a non-profit society dedicated to the development of pharmaceutical medicine as a professional discipline important to the discovery, development, registration, and marketing of innovative medicines.

1/1

© 2020 by Scleroderma Canada

  • Instagram - Black Circle
Scleroderma-Canada-Logo.png

SCLERODERMA

CONFERENCE